MedTrace Logo

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients

NCT01335230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2015-09-11

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to explore what role immune cells within the gut (the sigmoid colon) have locally and on the immune system of patients infected with HCV, HIV or HCV/ HIV co-infection.

Conditions

  • HIV
  • Hepatitis C, Chronic
  • HCV Coinfection

Sponsors & Collaborators

Principal Investigators

  • M. Tarek Shata, MD, PhD · University of Cincinnati

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01335230 on ClinicalTrials.gov